Trial Profile
A Multi Centre Randomised, Double Blind, Placebo Controlled, Parallel Group Comparison of the Effects of Cannabis Based Medicine Standardised Extracts Over 4 Weeks, in Patients With Chronic Refractory Pain Due to Multiple Sclerosis or Other Defects of Neurological Function
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2023
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis; Neurological disorders; Pain
- Focus Registrational; Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 22 Apr 2015 New trial record